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Plasmodium parasites cause malaria and 
are responsible annually for hundreds of 
thousands of deaths. Kinesins are a 
superfamily of microtubule-dependent 
ATPases that  play important roles in the 
parasite replicative machinery, which is a 
potential target for anti-parasite drugs. 
Kinesin-5, a molecular motor that 
crosslinks microtubules, is an established 
anti-mitotic targets in other disease 
contexts, but its mechanism in P. 
falciparum is unclear. Here, we 
characterised P. falciparum kinesin-5 
(PfK5) using cryo-EM to determine the 
motor’s nucleotide-dependent 
microtubule-bound structure,  and 
introduced 3D classification of individual 
motors into our microtubule image 
processing pipeline to maximise our 
structural insights. Despite sequence 
divergence in PfK5, the motor exhibits 
classical kinesin mechanochemistry, 
including ATP-induced subdomain 
rearrangement and cover neck bundle 
formation, consistent with its plus-ended 
directed motility. We also observed that 
an insertion in loop5 of the PfK5 motor 
domain creates a different environment in 
the well characterised human kinesin-5 
drug-binding site. Our data reveal the 
possibility for selective inhibition of PfK5 
and can be used to inform future 





Malaria is a massive disease burden 
world-wide, with an estimated 219 million 
cases in 2017, a year which also saw the 
first increase in cases for nearly two 
decades (1). With resistance to current 
frontline therapeutics rapidly rising (2–4), 
new drug targets are urgently needed. 
Malaria is caused by Plasmodium 
parasites, which are unicellular 
eukaryotes belonging to the Apicomplexa 
phylum. Malaria parasites have a complex 
life-cycle involving distinct stages that are 
transmitted between, and reproduce in, 
human and mosquito hosts (5). The 
cytoskeleton plays an important role 
throughout the parasite life cycle, and the 
microtubule (MT) based spindle 
machinery is involved in the many rounds 
of mitotic and meiotic replication required 
for parasite proliferation. Anti-mitotics 
are well-established as drugs in a variety 
of settings, notably human cancer (6) – 
thus, components of the malaria 
replicative machinery are attractive anti-
parasite targets. However, given the 
obligate intracellular nature of malaria 
parasites, any therapeutic target must be 
sufficiently divergent to be selectively 
disrupted compared to host homologues.  
 
Members of the kinesin superfamily are 
such potential targets. Kinesins are motor 
proteins that bind to MTs and convert the 
energy of ATP binding and hydrolysis into 
MT-based mechanical work. Different 
kinesin families have specialised 
functions, such as translocation of cargo 
along MTs, regulation of MT polymer 
dynamics, and organisation of higher-
order MT structures like mitotic and 
meiotic spindles (7, 8). MTs are built from 
heterodimers of the highly conserved α- 
and β-tubulin and, whereas there is 
approximately 95% sequence 
conservation of tubulins between 
Plasmodium sp. and Homo sapiens, 
sequence conservation within kinesin 
families is much lower, typically 40-50 %. 
This raises two important questions: do 
distantly related members of kinesin 
families diverge in their molecular 
properties, and could such sequence 











The kinesin-5 family are involved in cell 
division in many organisms, have long 
been investigated as an anti-mitotic 
therapeutic target for human cancer 9, 
and have also been considered as a target 
for anti-fungals 10. Kinesin-5 family 
members are found in most eukaryotes, 
including Plasmodium sp., and the family 
is predicted to have been established in 
the last eukaryotic common ancestor (11). 
Kinesin-5s form a tetrameric bipolar 
structure, with two opposing pairs of 
motor domains that can organise MT 
arrays such as those found in spindles 
(12–14). Several classes of selective Homo 
sapiens kinesin-5 (HsK5) inhibitors have 
been characterised that block motor 
ATPase activity and bind to allosteric sites 
in the motor domain. The best studied of 
these allosteric binding pockets is defined 
by kinesin-5-specific sequences in a key 
structural region of the motor domain, 
loop5 (15). Loop5 is critical for the correct 
operation of human kinesin-5, since its 
deletion or mutation disrupts the motor’s 
mechanochemical cycle (16–18). 
Furthermore, Drosophila kinesin-5 is 
resistant to the HsK5 inhibitor STLC, but 
can be sensitised by replacement of loop5 
with the cognate HsK5 sequence (19). The 
loop5-defined allosteric site thus has 
proven promise in mediating selective 
inhibition of kinesin-5 family members 
from different species. 
 
To investigate the idea that kinesin-5 from 
Plasmodium falciparum (PfK5) - the 
deadliest form of human malaria - could 
be a selective anti-malarial therapeutic 
target, we characterised the biochemical 
properties and MT-bound structure of the 
PfK5 motor domain. We show that the 
PfK5 motor domain is an ATPase with MT 
plus-end directed motility, as 
demonstrated in MT gliding experiments. 
MT-bound structures of the PfK5 motor 
domain were determined using cryo-
electron microscopy (cryo-EM), and 
processed in our RELION-based MT image 
processing pipeline (20). These structures 
reveal classical kinesin mechanochemistry 
despite the significant sequence 
divergence of this motor. This includes 
ATP-induced subdomain rearrangements 
that support neck-linker docking to the 
motor domain and cover neck bundle 
(CNB) formation, which together are 
consistent with PfK5 motor domain plus-
ended directed motility. Finally, we show 
that a large insertion in loop5 of the PfK5 
motor domain creates a different 
environment in the well characterised 
loop5 drug-binding site, revealing the 











PfK5ΔL6-MD is a slow ATPase  
To characterise PfK5 mechanochemistry, 
we first wanted to measure its MT-
stimulated ATPase activity. The PfK5 
motor domain (PfK5MD, amino acids 1-
493) contains a 105 amino acid asparagine 
and lysine rich insertion in loop6 that is 
characteristic of malaria proteins (21) 
(Figure 1A, left), but which is poorly 
conserved (16-30% sequence identity) 
among Plasmodium kinesin-5s. We 
engineered loop6 out of our construct, an 
approach previously taken by another 
group (22); this prevented the otherwise 
near-total precipitation of the non-
engineered protein during purification, 
thereby making all subsequent 
experiments feasible. We refer to this 
construct as PfK5ΔL6-MD, and it was 
purified to 99 % purity (Figure 1A, right).  
 
In the absence of MTs, PfK5ΔL6-MD 
exhibited a low ATP hydrolysis rate (Figure 
1B), but addition of MTs stimulated 
PfK5ΔL6-MD ATPase activity (Figure 1C). 
Changes in pH or ionic strength showed 
no or minimal impact respectively on 
PfK5ΔL6-MD ATPase rate (Figure S1A,B). 
From these data, the motor kcat and km of 
MTs (kMT) for PfK5ΔL6-MD was calculated. 
The km of ATP (KATP) was also determined 
(Figure 1D). PfK5ΔL6-MD has a MT-
stimulated ATP hydrolysis rate of 0.13 ATP 
s-1, which is slow compared to kinesin-5 
from S. pombe (23), S. cerevisiae (24), and 
H. sapiens (25) (with rates of 1.2, 0.5, and 
2.9 ATP s-1 respectively). However, 
PfK5ΔL6-MD has similar kMT (5.4 M) and 
KATP (9.5 M) values compared to 
previously characterised kinesin-5s (24, 
25). Thus, despite substantial sequence 
divergence, and although it has the lowest 
ATPase rate observed to date for the 
family, PfK5ΔL6-MD exhibits overall 
similar ATPase properties compared to 
other kinesin-5s. 
 
PfK5ΔL6-MD generates slow MT gliding  
To determine the motile properties of 
PfK5ΔL6-MD, we used a MT gliding assay. 
PfK5ΔL6-MD was expressed with a C-
terminal SNAP-tag (PfK5ΔL6-MD-SNAP), 
purified to 92 % purity (Figure 2A), 
covalently labelled with biotin, and 
attached to a neutravidin coated surface. 
The velocity of fluorescently-labelled MTs 
driven by PfK5ΔL6-MD-SNAP activity was 
measured. PfK5ΔL6-MD-driven MTs 
moved at an average velocity of 5.4 nm/s 
(95 % confidence interval = 5-5.9) (Figure 
2B, Figure S1C). This is slow compared to 
23-92 nm/s reported for HsK5-MD (23, 26, 
27). However, this slow MT gliding 
corresponds with the slow rate of ATP 
hydrolysis observed in the ATPase assay. 
Inclusion of polarity-marked MTs in the 
assay further showed that PfK5ΔL6-MD is 
a plus-end directed motor (Figure 2B). 
 
PfK5ΔL6-MD single molecule interactions 
with MTs 
To provide some context for the slow 
ATPase and MT gliding activity we 
observed for PfK5ΔL6-MD, we analysed 
the interactions of single molecules of 
fluorescently labelled PfK5ΔL6-MD-SNAP 
with MTs. We made single molecule 
measurements in different nucleotide 
conditions, to investigate how MT affinity 
changes with nucleotide state (Figure 2C, 
S1D), using the non-hydrolysable ATP 
analogue AMPPNP to mimic the ATP 
bound state. From these data, we 
calculated the MT association rate, or 
kMTlanding (Figure 2D), and MT dissociation 
rate, or koff of PfK5ΔL6-MD (Figure 2E). 
This demonstrated that in saturating ADP 
conditions, PfK5ΔL6-MD-SNAP had a 
comparatively low kMTlanding and a high koff, 
indicating that PfK5ΔL6-MD-SNAP has low 









2F). In the absence of nucleotide or in 
saturating AMPPNP conditions, PfK5ΔL6-
MD-SNAP had a comparatively high 
kMTlanding and a low koff, showing that when 
no nucleotide is present, or in its ATP-
bound state, PfK5ΔL6-MD-SNAP has high 
MT affinity.  
 
In saturating ATP conditions, kMTlanding was 
higher compared to the ADP state, 
however koff was similar, suggesting that 
PfK5ΔL6-MD-SNAP also has relatively low 
MT affinity in the presence of ATP. 
Overall, we observe that PfK5ΔL6-MD-
SNAP has high MT affinity in the no 
nucleotide and AMPPNP states compared 
to ADP and ATP saturating conditions, 
which is comparable to HsK5 (28). The 
identification of two high affinity states 
provided an opportunity to study the 
structure of the motor. 
 
MT-bound PfK5ΔL6-MD structure 
determination using cryo-EM 
To gain molecular insight into the 
behaviour of PfK5ΔL6-MD, its interaction 
with MTs and its sensitivity to nucleotide 
binding, we visualised MT-bound PfK5ΔL6-
MD in different nucleotide states using 
cryo-EM. We calculated 3D 
reconstructions of PfK5ΔL6-MD bound to 
MTs in the absence of nucleotide and in 
an ATP-like state, using AMPPNP (Table 
1). To do this we used MiRP (Figure 
S2A,B), our previously developed pipeline 
for image processing of MTs with RELION 
(20, 29). As part of the current study, we 
have updated MiRP to operate with 
RELION v3.1, and improved usability of 
the procedure such that it can be run 
from the RELION GUI, amongst other 
updates (see Methods and 
https://github.com/moores-lab/MiRPv2). 
 
PfK5ΔL6-MD binds MTs every 8 nm (one 
PfK5ΔL6-MD per αβ-tubulin) on the ridge 
of MT protofilaments (Figure 3A), a 
binding site shared by all other kinesins 
characterised to date (30, 31). MiRP 
initially produced reconstructions for the 
no nucleotide (Figure 3B, S2C) and 
AMPPNP states (Figure 3C, S2C) at overall 
resolutions of 4.8 Å and 4.5 Å 
respectively. The resolution in the MT 
region of both reconstructions is 
approximately 4.5-5.5 Å - in contrast, the 
resolution of PfK5ΔL6-MD exhibits a 
marked falloff as a function of distance 
from the MT surface (Figure S2C). This is 
typical of kinesin-MT reconstructions (32, 
33), and is attributable to a number of 
factors, including incomplete occupancy 
of the MT lattice by the motor that is not 
immediately apparent in the micrographs, 
as well as flexibility in the PfK5ΔL6-MD 
protein itself. We therefore used 
symmetry expansion and 3D classification 
focused on PfK5ΔL6-MD from one 
PfK5ΔL6-MD:αβ-tubulin dimer asymmetric 
unit to select data with the best PfK5ΔL6-
MD occupancy (Figure S2A). We rejected 
classes that had a clear absence of 
PfK5ΔL6-MD density, as well as classes 
which did not contain continuous motor 
density (Figure S2B). The resulting 3D 
structures (no nucleotide – Figure 3D, 
AMPPNP – Figure 3E) were substantially 
improved, as shown by reduced 
resolution decay in the motor domain 
density (Figure S2C,D). The average 
resolution of these reconstructions was 
4.4 and 4 Å for the no nucleotide and 
AMPPNP states respectively, with 
PfK5ΔL6-MD having a resolution range of 
4.5-7 Å. 
 
Alignment and superposition of our 
reconstructions directly reveals 
nucleotide-dependent differences in 
these structures (Figure S3A). However, to 
facilitate interpretation of the differences, 
we also calculated a PfK5ΔL6-MD 
homology model and performed flexible 









density, in which individual secondary 
structure elements were well resolved 
(Figure S3B). Local cross-correlation 
scoring showed overall improvement of 
model fit to density as a result of flexible 
fitting (Figure S3C), and produced 
molecular models of each of the PfK5ΔL6-
MD:αβ-tubulin dimer complexes (Table 1). 
These provide a detailed picture of how 
PfK5ΔL6-MD interacts with both α- and β-
tubulin. They also show that this divergent 
parasite motor has a canonical kinesin 
fold: it is built from a central β-sheet, 
sandwiched between three α-helices on 
each side, and flanked by a small β-sheet 
(β-lobe1), and a β-hairpin (β-lobe2) 
(Figure 3F,G). Using these models, we 
analysed conformational differences 
between the no nucleotide and AMPPNP 
states. 
 
AMPPNP binding causes PfK5ΔL6-MD 
nucleotide binding site closure 
The PfK5ΔL6-MD nucleotide binding site 
(NBS) is located away from the MT 
surface, and despite the overall low 
sequence conservation of PfK5ΔL6-MD 
compared to HsK5 (Figure S4), is 
composed of three loops containing 
conserved sequence motifs. These are the 
P-loop - which interacts with the α- and β-
phosphates of bound nucleotide - loop9 
and loop11, which contain the switch-I 
and switch-II motifs respectively (34). 
 
In the absence of bound nucleotide, 
density for all three NBS loops is visible in 
PfK5ΔL6-MD, although density for the P-
loop in the no nucleotide state is poorly 
defined (Figure 4A). In addition, density 
corresponding to the C-terminal end of 
loop11, which is approximately 19 Å from 
the NBS, and contains a two residue 
Plasmodium-conserved insertion, is not 
visible. In the no nucleotide state, density 
corresponding to loop9 and the P-loop are 
well separated, while density is observed 
connecting loop9 and 11 (Figure 4A). 
These configurations create an ‘open’ 
nucleotide binding site primed for ATP 
binding formed by a cavity between these 
three loops. Docking of a model of no 
nucleotide MT-bound kinesin-1 (35) into 
PfK5ΔL6-MD density reveals that the 
kinesin-1 switch loops fit poorly compared 
to the PfK5ΔL6-MD model, highlighting 
variations in the ‘open’ NBS conformation 
between kinesins (Figure S5A). In contrast 
to the no nucleotide state, in the AMPPNP 
state, there is clear density corresponding 
to the bound nucleotide in the PfK5ΔL6-
MD NBS (Figure 4A, S5B). In addition, the 
nucleotide is surrounded by loop9 and 11, 
which have closed around the bound 
nucleotide to form an NBS that supports 
ATP hydrolysis (Figure 4A) (36).  
 
Superimposing the PfK5ΔL6-MD no 
nucleotide and AMPPNP state models by 
alignment on αβ-tubulin allows 
visualisation of the structural response of 
the PfK5ΔL6-MD NBS to AMPPNP binding 
(Figure 4B), while docking of the AMPPNP 
state model into nucleotide density and 
vice versa confirms the structural 
differences between the two states 
(Figure S5C). Even while the resolution is 
not sufficient to determine the exact 
conformation of each of these loops, it is 
very clear that in the presence of 
AMPPNP, all three NBS loops move, with 
loop9 and the P-loop coming closer 
together, thereby burying the nucleotide. 
In summary, AMPPNP binding to PfK5ΔL6-
MD causes a conformational 
rearrangement that forms a closed, 
catalytically competent NBS. 
 
AMPPNP binding causes PfK5ΔL6-MD 
subdomain rearrangement 
What are the consequences of these NBS 
rearrangements on the structure of 
PfK5ΔL6-MD? The structure of PfK5ΔL6-









subdomains (37), which are predicted to 
move with respect to each other during 
the motor’s MT-based ATPase cycle 
(Figure 4C). The tubulin-binding 
subdomain (Figure 4C, purple hues) 
consists of MT binding elements in which 
helixα4 binds a shallow cavity at the intra-
tubulin dimer interface. In addition, 
helixα5 and β-lobe2 contact β-tubulin. 
The remaining two subdomains, the P-
loop subdomain (Figure 4C, blue hues) 
and switch-I/II subdomain (Figure 4C, 
green hues), contain approximately half of 
the central β-sheet each, along with 
adjacent secondary structure elements. 
The NBS is located at the junction of these 
subdomains (Figure 4C). 
 
We measured the relative rotation of 
each helix (Table S1) in the transition from 
no nucleotide to AMPPNP states. This 
reveals the rearrangement of the P-loop 
and switch-I/II subdomains around a static 
MT binding domain (Figure 4D). The P-
loop subdomain pivots such that helixα0 
moves towards the MT surface, while 
helixα6 and the majority of the 
subdomain moves away from the MT 
surface. The switch-I/II subdomain rotates 
such that its constituent secondary 
structure elements move towards β-
tubulin.   
 
AMPPNP binding supports PfK5ΔL6-MD 
neck linker docking and cover neck 
bundle formation 
What are the consequences for these 
subdomain rearrangements for the 
functional output of PfK5ΔL6-MD? 
Approximately 18 Å away from the MT 
surface, and 27 Å away from the NBS, is 
the neck linker. The neck linker is a C-
terminal peptide extending from helixα6, 
which links the motor domain to the 
kinesin stalk, and which is relatively 
conserved in the kinesin superfamily 
(Figure S6A). In the PfK5ΔL6-MD no 
nucleotide reconstruction, no density is 
observed extending from helixα6, 
indicating that the neck linker is 
disordered in this nucleotide state (Figure 
5A, Figure S6B). At equivalent thresholds 
in the AMPPNP state however, there is 
clear density corresponding to the neck 
linker at the C-terminus of helixα6 that 
extends along the motor domain in the 
direction of the MT plus-end (Figure 5B). 
Docking of the AMPPNP state model into 
no nucleotide density confirms a lack of 
density to accommodate the neck linker, 
while density is unaccounted for when the 
no nucleotide model is docked in AMPPNP 
density (Figure S6C). In addition, density 
corresponding to the PfK5ΔL6-MD N-
terminus is also visualised in the AMPPNP 
state; this is consistent with formation of 
backbone interactions between this 
region and the neck linker, to form short 
β-strands known as the cover neck bundle 
(CNB), which is characteristic of plus-end 
directed kinesins (38) (Figure 5B, dotted 
black oval; S6B). No such CNB density is 
observed in the no nucleotide 
reconstruction (Figure S6B). Neck linker 
docking is enabled by the above-described 
rotation of the P-loop subdomain, which 
moves the N-terminus and the central β-
sheet away from helixα5/loop13 in the 
static MT binding subdomain (Figure 4D) 
(39–42). This creates a cavity between 
loop13 and the N-terminus, known as the 
docking cleft, which enables neck linker 
docking. Thus, PfK5ΔL6-MD subdomain 
rearrangement causes opening of the 
docking cleft upon AMPPNP binding, a 
structural transition that is consistent with 
the ability of PfK5ΔL6-MD to drive ATP-
dependent plus-end directed gliding 
motility (37). 
 
MT binding interface 
PfK5ΔL6-MD binds to one αβ-tubulin 
dimer, with helixα4 centred at the intra-









PfK5ΔL6-MD binding site, the sequence of 
the S. scrofa αβ-tubulin used in our 
reconstruction is identical to that of P. 
falciparum αβ-tubulin (Figure S7),  
facilitating a more detailed investigation 
of this interface. To analyse which 
PfK5ΔL6-MD secondary structure 
elements interact with αβ-tubulin in the 
no nucleotide state, we coloured an αβ-
tubulin surface representation according 
to different PfK5ΔL6-MD secondary 
structure elements; we also coloured 
PfK5ΔL6-MD according to proximity to α 
or β-tubulin (Figure 6C). This analysis 
shows that helixα4 interacts with both α- 
and β-tubulin,  
while βlobe1, loop11 and helixα6 interact 
with helices 4, 5 and 12 of α-tubulin, and 
loop7, βlobe2 and helixα5 interact with 
similar secondary structure elements in β-
tubulin. 
 
Much of this PfK5ΔL6-MD-MT interface is 
similar between the no nucleotide and 
AMPPNP states, (Figure 6D, Table S2). 
However, subdomain re-arrangement and 
NBS closure in the AMPPNP state result in 
some changes. The largest of these occurs 
at the α-tubulin interface, where rotation 
of the P-loop subdomain decreases the 
interaction of helixα6 with α-tubulin, and 
positions βlobe1 closer to α-tubulin, 
increasing its interface area. The interface 
area of loop11 also increases in the 
AMPPNP state. Interestingly, 
βlobe1/loop2 forms an interface area with 
α-tubulin of 181 and 145 Å2 in the no 
nucleotide and AMPPNP states 
respectively. Taken together, this shows 
that the PfK5ΔL6-MD-MT interface is 
similar to that observed for other kinesin-
5s, although the extent to which 
βlobe1/loop2 interacts  with α-tubulin 
differs between different family members 
(10, 23, 43). 
 
PfK5ΔL6-MD loop5 forms a unique 
putative drug binding site 
Loop5 plays an important role in the 
mechanochemistry of HsK5 (16, 18), and 
forms the drug binding pocket of HsK5-
specific inhibitors 19. It is a solvent 
exposed loop that creates a break in 
helixα2, and protrudes from the surface of 
the motor domain away from the MT. The 
loop5 sequence is well conserved 
between Plasmodium species (76-91 % 
sequence identity), and is longer 
compared to HsK5 (Figure 7A). In the no 
nucleotide state of PfK5ΔL6-MD, some 
very poorly defined density corresponding 
to loop5 can be seen at a low threshold 
(Figure 7B), suggesting that this region is 
largely disordered in this state.  
 
In the AMPPNP state, however, clear 
density corresponding to loop5 can be 
seen, which forms two distinct regions. 
This density extends at an angle from 
helixα2, forming elongated density 
projecting from the motor domain 
between helixα1 and helixα3 (Figure 7C). 
This region is at lower resolution than 
other parts of the reconstruction, possibly 
owing to intrinsic flexibility, but also 
possibly because of the residual 
resolution gradient towards the outer 
surface of PfK5ΔL6-MD (Figure S2C). 
There is no secondary structure-like 
density in this region of the motor, 
consistent with sequence-based 
predictions (Figure S4) and, therefore, a 
model for PfK5ΔL6-MD loop5 was not be 
calculated.  
 
Strikingly, however, the density 
corresponding to loop5 in the AMPPNP 
state does not protrude away from the 
surface of the motor but appears to cover 
the site between helicesα2 and 3, 
equivalent to the well described inhibitor 
binding site in HsK5. Docking of a crystal 








characterised inhibitor STLC in the 
PfK5ΔL6-MD density reveals the poor 
match between HsK5 loop5 and the 
PfK5ΔL6-MD loop5 density (Figure 7D). 
This also suggests that, although residues 
outside of loop5 involved in interactions 
with STLC are largely conserved between 
HsK5 and PfK5 (Figure 7E), loop5 of 
PfK5ΔL6-MD might alter the environment 
of this putative drug binding site. To test 
this idea, we measured whether the 
ATPase activity of PfK5ΔL6-MD was 
susceptible to inhibition by STLC (44). 
Consistent with our structural prediction, 
while STLC inhibits HsK5 ATPase activity, it 
does not inhibit PfK5ΔL6-MD (Figure 7F). 
Thus, despite the conserved aspects of 
PfK5ΔL6-MD mechanochemistry 
uncovered by our data, evolutionary 
divergence between PfK5ΔL6-MD and 
HsK5 mediates differential inhibition of 











We have determined the biochemical 
properties and MT-bound cryo-EM 
structures of a spindle-associated kinesin-
5 motor from the malaria parasite. 
Despite considerable divergence from the 
human host kinesin-5 sequence, our P. 
falciparum kinesin-5 PfK5ΔL6-MD 
construct shares with HsK5 a 
comparatively slow MT-stimulated 
ATPase, plus-end directed MT gliding 
activity and nucleotide-dependent 
conformational changes that support 
plus-end directed motility. Significantly, 
however, our structures revealed a 
different configuration of the well 
characterised loop5-defined drug binding 
pocket. Further, we also showed that 
PfK5ΔL6-MD exhibits no sensitivity to the 
classical HsK5 loop5 binding drug STLC. 
 
The steady state ATPase activity of 
PfK5ΔL6-MD is ~340 times slower than H. 
sapiens kinesin-1 (42), 3-25 times slower 
than other members of the kinesin-5 
family (24, 25, 43), and its MT gliding 
activity is similarly and proportionally 
slow. Our use of mammalian brain tubulin 
rather than native P. falciparum tubulin 
might, in principal, contribute to this - 
however, αβ-tubulin is well conserved 
between S. scrofa and P. falciparum, and 
the two species have identical residues at 
the kinesin binding site (Figure S7), 
suggesting that tubulin source is unlikely 
to influence PfK5ΔL6-MD activity. In 
further support of this, experiments 
comparing ATPase rates of a yeast 
kinesin-5 motor domain interacting with 
mammalian and yeast tubulin showed no 
difference (43). A previous study of 
Plasmodium falciparum and vivax kinesin-
5s also observed slow ATPase rates for 
these motors (22). These findings are 
reminiscent of the properties of other 
kinesin-5s and indeed, this may be critical 
for their function – substitution of the 
slow motor activity of vertebrate kinesin-5 
with faster kinesin-1 was functionally 
disruptive in the complex context of the 
spindle (46). This suggests that PfK5 – like 
other kinesin-5s – operates in motor 
ensembles, where slow-moving teams of 
PfK5 collaborate to drive MT organisation 
(13).  
 
The malaria kinesin-5 protein we studied 
was engineered to remove a low-
complexity region in loop6, a strategy that 
had previously been adopted both in 
characterising malaria kinesin-5 (22) and 
other malaria proteins (47). The insertion 
point of loop6 lies approximately 40 Å 
from the NBS and, although we cannot 
exclude that removal of this region 
influences PfK5ΔL6-MD’s behaviour, our 
structures clearly demonstrate that the 
engineered protein adopts a canonical 
kinesin fold and undergoes a structural 
response to AMPPNP binding. Loop6 
residues are therefore not required for 
protein folding and fundamental kinesin 
mechanochemistry. Low-complexity 
regions like PfK5 loop6 are very common 
in malaria proteins, and are often found 
inserted in otherwise well-conserved 
three-dimensional folds (21). While the 
role of such low-complexity regions in 
immune evasion is logical for extracellular 
parasite proteins (48), it remains unclear if 
and how such regions modulate 
intracellular protein function.  
 
Improvements of our MiRP image analysis 
procedures allowed us to efficiently 
handle the incomplete binding of 
PfK5ΔL6-MD along the MTs in our cryo-
EM data (Figure S2) and to clearly 
visualise MT-bound PfK5ΔL6-MD at 5-6 Å 
resolution. Our structures showed that 
PfK5ΔL6-MD exhibits an open-to-closed 
conformational change in the NBS, kinesin 









cover neck bundle formation on ATP 
analogue binding, typical of a classical 
plus-end kinesin (35, 42, 49). The lowest 
resolution region of our PfK5ΔL6-MD is its 
MT-distal surface, which encompasses the 
potential drug-binding loop5 region. 
Because we used GMPCPP-stabilised MTs, 
we do not think that MT lattice 
discontinuities – that can occur on 
paclitaxel-stabilised MTs (33, 50) – cause 
this resolution loss. Rather, loop5 of 
PfK5ΔL6-MD, which is 21 residues longer 
than in HsK5 and composed mainly of 
hydrophilic residues, appears to be 
intrinsically flexible and thus its 
conformation is more challenging to 
capture structurally. Density for loop5 is 
only well defined in the AMPPNP state 
and not the no nucleotide state, 
suggesting it is conformationally sensitive 
to bound nucleotide, as also observed 
with HsK5 loop5 (51). Strikingly, density 
attributable to loop5 impinges on the 
pocket corresponding to the well-
characterised drug binding site in HsK5 
(52) and provides a possible explanation 
for the lack of sensitivity of PfK5ΔL6-MD 
to inhibition by the small molecule STLC. 
Given the strong sequence conservation 
in loop5 between different Plasmodium 
species, this encouraging finding raises 
the possibility of selective inhibition of 
parasite motors. Indeed, a small molecule 
screen identified a compound able to 
inhibit Plasmodium kinesin-5 ATPase 
activity, but not that of HsK5 (22).  
 
P. berghei kinesin-5 localises to mitotic 
and meiotic spindles in blood and 
mosquito stages of the parasite life cycle 
(53), consistent with a conserved role for 
this motor in the parasite cell division 
machinery. Although we know very little 
else about the function of this motor, we 
infer from our biochemical and structural 
data that Plasmodium kinesin-5 is likely to 
play a MT-organising role within parasite 
spindles. Kinesin-5 is not essential during 
the blood stages of the Plasmodium life 
cycle (53, 54). However, knockout of P. 
berghei kinesin-5 substantially reduces 
the number of sporozoites in oocysts and 
mosquito salivary glands. This highlights 
the operational diversity of replication at 
different parasite life cycle stages in 
general, and specifically suggests a key 
role for kinesin-5 in the multiple rounds of 
mitosis that occur during sporozoite 
production in the mosquito host (53).  
 
There is increasing focus on tackling 
malaria not only during the symptomatic 
blood stages of the parasite life cycle but 
also by perturbing Plasmodium 
transmission between vector and host to 
facilitate malaria control at the population 
level (55). Intriguingly, despite the 
reduction of sporozoite numbers in 
kinesin-5 knockout parasites, the residual 
sporozoites achieved normal infectivity. 
Nevertheless, the role of kinesin-5 in this 
life cycle stage sheds light on parasite 
transmission vulnerabilities. Particularly 
given the distinct parasite number 
threshold that supports onward 
transmission between vector and host 
(56), combinations of perturbations that 
reduce overall sporozoite production 
could enable transmission control. 
Moreover, the diverse mechanisms by 
which small molecules can inhibit HsK5 
function have demonstrated that some 
modes of motor inhibition can be more 
functionally disruptive than preventing 
MT binding or than removing motor 
function completely, for example by 
trapping it in a tightly bound MT state 
(23). In fact, tight MT binding is the 
proposed mechanism for the anti-fungal 
small molecules that target C. albicans 
kinesin-5, despite that motor being non-
essential (57). In the context of these 

















Protein expression and purification  
The PfK5 motor domain (PfK5MD, residues 1-493) was expressed and purified, but with low 
yield due to precipitation during purification. Therefore, PfK5MD was engineered such that 
105 amino acids of the asparagine/lysine rich insertion in loop6 (residues 175-269) were 
removed. The resulting construct, which we refer to as PfK5ΔL6-MD, was cloned in a pET-
151D-TOPO vector (Invitrogen) with an N-terminal His6-tag and TEV protease cleavage site, 
and each preparation was expressed in 12 L BL21 Star DE3 E. coli cells (Invitrogen) grown 
in LB media. Cells were grown at 37oC until they reached an optical density of 0.8-1.0, and 
were then induced with 0.1 mM IPTG for 3 hours at 26oC. Cells were harvested (6,300 g, 15 
mins, 4oC) and stored at -80oC.  
 
Cells were lysed with 3 passages through a C3 homogeniser (Avestin) in 100 mL IMAC W 
buffer (50 mM Tris-HCl pH 8, 400 mM NaCl, 2 mM MgCl2, 2 mM DTT, 1 mM ATP, 10 mM 
imidazole pH 8), which was supplemented with 2 x cOmplete EDTA-free protease inhibitor 
tablets (Roche), 15 g/mL DNase I (Roche), 0.5 mg/mL Lysozyme, 10 % v/v glycerol. The 
lysate was then clarified by centrifugation (48,000 g, 45 mins, 4oC). PfK5ΔL6-MD was 
purified from the clarified lysate at 4oC using an ÄKTA Pure (GE Healthcare) in one day, 
which reduced loss of protein due to aggregation. First, nickel affinity chromatography was 
performed where the lysate was loaded onto a 5 mL HisTrap Excel column (GE 
Healthcare), followed by a wash with 20 column volumes (CV) of IMAC W, then reverse 
elution with 10 CV of IMAC E buffer (same composition as IMAC W, but with 300 mM 
imidazole). The eluate from this step was concentrated to 10-15 mL with a Vivaspin 
concentrator (Sartorius). Concentrated sample was then exchanged into IEX W buffer (same 
as IMAC W, except containing 80 mM NaCl and no imidazole) using a HiPrep 26/10 desalting 
column (GE Healthcare). Next, anion exchange chromatography (1 mL HiTrap Q HP) was 
performed, where the flow-through and wash fractions containing PfK5ΔL6-MD were 
pooled. The His6-tag was then cleaved by incubation with 100 g/mL TEV protease for 2-4 
hours at 4oC. TEV-protease and any remaining contaminants were removed using nickel 
affinity chromatography (1 mL HisTrap HP), where flow-through and wash fractions 
containing PfK5ΔL6-MD were pooled. PfK5ΔL6-MD was concentrated to 100-150 L then, 
using 0.5 mL Zeba 7K MWCO spin columns, was exchanged into T50K20 buffer (50 mM 
Tris-HCl pH 8, 20 mM KCl, 2 mM MgCl2, 2 mM DTT). This purified PfK5ΔL6-MD was snap 
frozen in liquid nitrogen and stored at -80oC. PfK5ΔL6-MD purity was measured using 
Coomassie-stained SDS-PAGE band intensity measurement in Fiji (58). 
 
Protein labelling 
Gibson assembly (59) was used to clone in-frame a C-terminal SNAP-tag on PfK5ΔL6-MD 
(PfK5ΔL6-MD-SNAP) for use in total internal reflection microscopy (TIRFM) experiments. 








the anion exchange chromatography step was altered as follows: concentrated and desalted 
sample was added to a 1 mL HiTrap Q HP column, washed with 10 CV IEX W buffer, and 
eluted with a 20 CV gradient elution to 500 mM NaCl. Eluted fractions containing PfK5ΔL6-
MD-SNAP were pooled. PfK5ΔL6-MD-SNAP was biotinylated or fluorescently labelled by 
overnight incubation at 4oC with SNAP-Biotin  or SNAP-Surface Alex Fluor 647 (New 
England BioLabs) with at least a 3:1 molar excess of these labels to PfK5ΔL6-MD-SNAP. Free 
SNAP-ligand was removed by 2 repeats of buffer exchange in T50K20 buffer (0.5 mL Zeba 
7K MWCO spin columns).  
 
MT Preparation 
Purified and lyophilised unlabelled, X-rhodamine labelled, or biotin labelled Sus scrofa brain 
tubulin - except X-rhodamine which was from Bos taurus - (catalogue numbers T240C, 
TL620M T333P, respectively, all >99% pure, Cytoskeleton Inc.) was reconstituted to 10 
mg/mL in BRB80 (80 mM PIPES pH 6.8, 2 mM MgCl2 1 mM EGTA pH 6.8), centrifuged at 
611453 g for 10 mins at 4oC, and the supernatant snap frozen in liquid nitrogen and stored 
at -80oC. Double cycle GMPCPP polymerisation was performed as follows: reconstituted 
tubulin was supplemented with 1 mM GMPCPP (Jena Biosciences) and incubated for 5 mins 
on ice. Tubulin was then polymerised at 4-5 mg/mL for 20 mins at 37oC. MTs were then 
pelleted at 611453 g for 10 mins at 23oC, washed twice, then resuspended, both with 
BRB80. MTs were then depolymerised on ice for 15 mins, and a second round of 
polymerisation performed as above. MTs for the ATPase assay were pelleted on a 50 % v/v 
sucrose/BRB80 cushion after the second polymerisation, to aid separation of MTs from 
unpolymerised tubulin.  
 
For labelled MTs, X-rhodamine and unlabelled tubulin were mixed in a 1:9 ratio, or X-
rhodamine, biotinylated, and unlabelled tubulin were mixed in a 1:1:8 ratio and polymerised 
at approximately 4 mg/mL total tubulin with 1 mM GTP at 37oC for 20 mins. 40 M 
Paclitaxel (Merck) dissolved in DMSO was then added, followed by a further incubation at 
37oC for 15 mins, and then incubation at room temperature for at least one day before use. 
To prepare polarity marked MTs (60), long, dimly labelled MTs (1:9 ratio of X-rhodamine to 
unlabelled tubulin) were polymerised at 2 mg/mL total tubulin for 2 hours with 1 mM 
GMPCPP. To prepare NEM-tubulin, by which minus-end MT growth is blocked, 8 mg/mL 
unlabelled tubulin was incubated with 1 mM N-ethyl maleimide (Sigma) on ice for 10 mins, 
then with 100 mM ß-mercaptoethanol (Sigma) for 10 mins. To polymerise the bright plus 
end MT cap, NEM-tubulin was mixed 1:1 with X-rhodamine tubulin and incubated at 37 oC 
for 15 mins. Finally, long, dim MTs were pelleted (15 mins, 17,000 g, room temp.), the pellet 
resuspended with bright MT caps, incubated 37oC for 15 mins, then 40 M paclitaxel added. 
 
Steady-state ATPase activity  
An NADH-coupled ATPase assay (61) containing 1.5 mM Phosphoenolpyruvate (Sigma), 9-15 
U/mL pyruvate dehydrogenase (Sigma), 13.5-21 U/mL lactate dehydrogenase (Sigma) and 
0.25 mM NADH (Roche) was used to measure PfK5ΔL6-MD ATPase rates. Reactions were 
performed in T50K40 buffer (50 mM Tris-HCl pH 8, 400 mM KCl, 2 mM MgCl2, 2 mM DTT) 
with 100-200 nM PfK5ΔL6-MD. A340 readings were taken on a SpectraMax 384 (Molecular 
Devices) from 100 L reactions at 26oC, with automatic path length correction to 1 cm, 
taking readings every 10 s for 30 mins. Background readings containing no PfK5ΔL6-MD 









Beer-Lambert equation, and kcat calculated using the Michaelis-Menten equation with the 
term K0 (rate at substrate concentration of 0). 
 
𝐴𝑇𝑃 𝑠−1 𝑠𝑖𝑡𝑒−1 =  




MT gliding and single molecule TIRFM assays 
TIRFM assays with fluorescently labelled protein were performed in a flow-chamber, 
created by adhering biotin-PEG coverslips (MicroSurfaces Inc.) to glass slides with double-
sided tape. To prepare flow-chambers for the MT gliding assay, the following treatments 
were made. (1) 0.75 % Pluronic acid + 5 mg/mL casein was added for 5 min, and the 
chamber was washed with T50K20 buffer + 20 M paclitaxel (T50T). (2) 0.5 mg/mL 
neutravidin was added for 2 mins, then the chamber was washed twice with T50T + 1 
mg/mL casein (T50TC). (3) 1-2.5 M PfK5ΔL6-MD-SNAP was added for 2 mins, then washed 
twice with T50TC. (4) Finally, T50TC supplemented with 20 mM glucose, 300 M glucose 
oxidase, 60 g/mL catalase, 71 mM ß-mercaptoethanol, and 0.5 M X-rhodamine MTs was 
added. For single molecule experiments, the same preparations were performed with the 
following exceptions. (3) 0.5 M X-rhodamine/biotin MTs were added for 2 mins, then 
washed twice with T50TC. (4) as above, except 1-100 nM PfK5ΔL6-MD-SNAP-alexa647 was 
added instead of MTs. 
 
Fluorescent molecules were visualised on an Eclipse Ti-E inverted microscope with H-TIRF 
illuminator, LU-N4 laser unit, and CFI Apo TIRF 1.49 N.A. oil objective lens 100x (Nikon) (62). 
Images were recorded on an iXon DU888 Ultra EMCCD camera (Andor) with 60-100 ms 
exposures. MT velocity and parameters of PfK5ΔL6-MD-SNAP MT binding were calculated 
from kymographs generated in FIJI (58). For MT binding, only events >= 3 frames were 
considered. Mean dwell time/koff was calculated by fitting a one-phase exponential decay 
model to the data. Background kon rates were measured by randomly sampling areas 
without MTs in the ADP and ATP states, because these states had high background binding, 
owing to the high concentrations needed to observe PfK5ΔL6-MD-SNAP binding events 
 
Cryo-EM sample preparation, imaging, and data processing 
Nucleotide-free PfK5ΔL6-MD was prepared by incubation with 10 U/mL apyrase (Sigma) for 
at least 15 mins at 4 oC, to remove any nucleotides still present following purification. 
UltrAuFoil 1.2/1.3® gold (Quantifoil) electron microscopy grids were glow discharged in air 
for 1 min at 0.3 mpa using a PELCO easiGlow (Ted Pella, Inc.). Using a Vitrobot Mark IV 
(ThermoFisher), with the chamber set to 23oC and 95 % humidity, 4 L of 3.5 M GMPCPP 
MTs were added to grids and incubated for 30 s, then blotted. 4 L of 50 M no nucleotide 
PfK5ΔL6-MD was then immediately added, incubated for 30 s, then blotted. A second round 
of PfK5ΔL6-MD was added before blotting and plunge freezing into an ethane slush. 
AMPPNP PfK5ΔL6-MD was prepared by incubation with 5 mM AMPPNP (R&D Systems) for 
at least 5 mins at 4 oC. Vitrification was performed as above, except using C-flat 2/2™ carbon 
(Protochips) holey grids with 5 M GMPCPP MTs.  
 
Imaging was manually or automatically performed on a G2 Polara (FEI/ThermoFisher) 









counting mode, with a GIF Quantum LS Imaging Filter (Gatan). The sample was exposed with 
58 e-/ Å2 for 18 sec and 60 frames collected with a pixel size at the sample of 1.39 Å. 
 
All image processing steps were performed with RELION v3.0 and 3.1 (29, 64) except where 
otherwise noted. Beam induced motion in micrographs was corrected using RELION’s 
implementation of MotionCor2, and the CTF was determined for each micrograph using 
Gctf (65). The start/end coordinates of each MT were manually assigned, and MT particles 
with a box size of 432 pixels were extracted every 82 Å and normalised. Alignment and 
asymmetric reconstruction of 14 protofilament (PF) MTs (which are the dominant MT type 
in GMPCPP preparations (66)) was performed using MiRP (20), as follows, with new MiRP 
updates noted (Figure S2). RELION parameters used for MiRP PF sorting, initial seam 
alignment and seam checking steps are listed in Table S3. Briefly, PF number assignment for 
each MT was performed with supervised 3D classification. As part of the MiRP update 
undertaken during this work, after 3D classification, PF number class assignments for each 
MT were smoothened by calculating the mode of class assignment over a 7 particle window. 
Where changes in class assignment occurred within a single MT – due to for example, 
changes in PF number or major defects within a single MT - MT regions were subsequently 
treated as distinct MTs. This improved the homogeneity of each MT, increasing confidence 
in protofilament number assignment and seam location determination. Initial seam 
alignment was then performed with several iterations of 3D alignment. This was followed, 
as previously, by Rot angle and X/Y coordinate fitting – however, a local search step was 
added to improve Rot angle and X/Y shift assignment. Seam checking via supervised 3D 
classification was then performed, and MTs with less than 50 % confidence in seam class 
assignment were removed. C1 reconstructions were obtained with a 3D auto-refine run 
(using the parameters for X/Y refine in Table S3, with a solvent mask obtained from a 3D 
reconstruction of seam checking results), followed by per-particle CTF refinement, Bayesian 
polishing, and beam-tilt estimation, then a second 3D auto-refine with these new 
corrections. MiRP was also updated to improve useability, by creating three programs for 
each MiRP step that can be operated from the RELION v3.1 GUI 
(https://github.com/moores-lab/MiRPv2). 
 
Symmetrised maps were obtained by first performing 2D classification without alignment 
(200 classes, T = 8), and selecting well-aligned classes with many particles and an estimated 
resolution better than 6 Å. A 3D auto-refine run was then performed where 14-fold local 
symmetry was applied, as previously described (67). To address PfK5ΔL6-MD heterogeneity, 
3D classification was performed at the level of a PfK5ΔL6-MD:αβ-tubulin asymmetric unit. 
For this, symmetry expansion was applied to all particles, then 3D classification (4 classes, T 
= 256) without alignment and a mask around one PfK5ΔL6-MD site opposite the seam was 
applied. This resulted in one class with clear PfK5ΔL6-MD decoration, which was selected 
and subjected to a 3D auto-refine procedure. The MT-bound nucleotide-free and AMPPNP-
bound PfK5ΔL6-MD reconstructions are deposited with the Electron Microscopy Data Bank, 
deposition number 12257 and 12258 respectively. 
  
Sequence analysis, comparative modelling and flexible fitting 
To obtain a kinesin-5 family sequence alignment, the motor domains all kinesin-5 family 
members in the Swiss-Prot database were aligned with MAFFT (68). A hidden Markov model 









database using HMMER (69). Sequences obtained were then compared to a kinesin profile 
from the Pfam database (70), and those with less than 400 identities were removed. Finally, 
the sequences were aligned with MAFFT, using the L-INS-i method (Supplemental Data File 
1). Secondary structure prediction was performed using Quick2D (71), using various 
prediction algorithms (72–76). A residue was assigned helical or beta-sheet identity if 3 or 
more prediction algorithms agreed. 
 
The above sequence alignment was used in homology modelling of PfK5ΔL6-MD, using the 
human kinesin-5 AMPPNP bound crystal structure (PDB ID: 3HQD (36)) as a template. For 
this, 100 homology models were produced with Modeller v9.2 (77), then scored using 
QMEAN (78) and the top model selected. Restraints used to model the extended helixα2 
and for highly conserved positions in the nucleotide binding site are listed in Table S4. 
Flexible fitting of PfK5ΔL6-MD secondary structure elements into no nucleotide and 
AMPPNP cryo-EM reconstructions was performed using Flex-EM (79) (cap shift = 0.15) after 
rigid body docking of the top homology model using the Fit in Map tool in Chimera (80). 
During this procedure, the nucleotide binding site (AMPPNP, Mg2+, switch-I/II loops, and the 
P-loop) was defined as a rigid body, while loop regions were treated as “all atoms”. Models 
of the N-terminus, loops 2, 8, 9, 10, 11, and 12, and the neck linker were predicted using 
Rosetta, firstly using a coarse method (500 models using cyclic coordinate descent with 
fragment insertion in the centroid modelling step (81)), then the model with highest cross-
correlation was selected for a second prediction (500 models using kinematic closure with a 
fit to density term in the centroid modelling step (82)). A local all-atom fit to density step 
was then performed using the Rosetta Relax procedure including a fit to density term (83). 
Finally, the interface between PfK5ΔL6-MD and αβ-tubulin was refined with protein-protein 
docking restrained by cryo-EM density in HADDOCK (84) as described previously (32), using 
the PDB ID 3JAT (85) as αβ-tubulin atomic model. SMOC scores were calculated using the 
TEMPy software package (86, 87). The molecular models of MT-bound nucleotide-free and 
AMPPNP-bound PfK5ΔL6-MD are deposited with the Worldwide Protein Data Bank, 
deposition number 7NB8 and 7NBA respectively. 
 
Visualisation and analysis 
Plotting was performed with GraphPad Prism 8. Cryo-EM density and model analysis was 
done in Chimera (88) and ChimeraX (89). Protein sequence analysis was done in Jalview 























This article contains supporting information. 
Data file 1: Kinesin-5 motor domain sequence alignment. 
Figures S1 - S7 
Table S1 – S4 
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Figure 1. PfK5ΔL6-MD is a slow MT-stimulated ATPase. (A) Left, Domains of full-length PfK5 
and PfK5ΔL6-MD, displaying the N-terminus (Nt), motor domain (MD), neck linker (NL), stalk 
(S), C-terminus (Ct) aa = amino acids; right, Coomassie-stained SDS-PAGE of PfK5ΔL6-MD 
after purification. (B) PfK5ΔL6-MD ATPase rate in the absence of MTs. Technical replicates = 
12 (circles), experimental replicates = 4 (triangles), biological replicates (i.e. number of 
different protein purifications used in the experiments) = 2. The mean of experimental 
replicates (0.039 ATP s-1) and 95 % confidence interval are plotted. (C) PfK5ΔL6-MD MT 
stimulated ATPase activity. The mean and standard deviation of 3 experimental replicates 
(no technical replicates), are plotted. Biological replicates = 2. The fit is plotted as a blue 
line, with corresponding 95 % confidence interval plotted as black lines. Inset displays an 
example of raw data (A = ATP, P = PfK5ΔL6-MD, and M = MTs). (D) PfK5ΔL6-MD MT 
stimulated ATPase activity as in (C), except with ATP as the substrate variable, and using a 
constant of 1 μM MTs. 
 
Figure 2. PfK5ΔL6-MD drives plus-end directed MT gliding and its MT interactions are 
nucleotide modulated. (A) Schematic of the PfK5ΔL6-MD-SNAP fusion protein used for 
TIRFM experiments, and SDS-PAGE of PfK5ΔL6-MD-SNAP after purification. * indicates the 
band for PfK5ΔL6-MD-SNAP. (B) PfK5ΔL6-MD-SNAP driven MT gliding velocity. Technical 
replicates = 75 (circles), experimental replicates = 5 (triangles), biological replicates = 3. The 
mean of experimental replicates (5.4 nm/s) and 95 % confidence interval are plotted. 
Greyscale images on the right are snap-shots of a single bright plus-end labelled MT over 
time. (C) Example kymographs from PfK5ΔL6-MD-SNAP single molecule MT binding 
experiments, with each vertical white streak corresponding to a single PfK5ΔL6-MD-SNAP 
binding event. Concentrations refer to the amount of PfK5ΔL6-MD-SNAP required to see 
single molecule binding for each nucleotide. (D) PfK5ΔL6-MD-SNAP MT association rates in 
different nucleotide states (NN = no nucleotide). For each nucleotide condition, technical 
replicates (circles) and experimental replicates (triangles) are plotted, in addition to the 
mean and 95 % confidence interval of experimental replicates. Number of MTs = 34, 22, 46, 
28, 29 for the background, ATP, ADP, no nucleotide, and AMPPNP states respectively. (E) 
Frequency distribution of PfK5ΔL6-MD-SNAP MT dwell times, in different nucleotide states. 
Number of experimental replicates = 3, however frequency distributions are calculated from 
pooled experimental data. Number of biological replicates = 2. The fit for one-phase 
exponential decay models is shown, with corresponding decay constant (koff). Number of 
events = 1065, 1084, 1799, 1717 for ATP, ADP, no nucleotide, and AMPPNP states 
respectively. (F) Mean MT association (kMTlanding) as a function of MT dissociation (koff), 
plotted with 95 % confidence intervals. 
 
Figure 3. Cryo-EM 3D reconstruction of PfK5ΔL6-MD MT complexes. (A) Example 
micrograph of the PfK5ΔL6-MD bound MTs with 5 mM AMPPNP. White arrows indicate 
PfK5ΔL6-MD decoration present every 8 nm (1 αβ-tubulin dimer). (B-E) 3D reconstructions 
have been locally low-pass filtered according to local resolution. (B) The unsymmetrised (C1) 
reconstruction of the PfK5ΔL6-MD no nucleotide state bound to MTs, depicting the central 
portion of the MT reconstruction. (C) as in (B), for the AMPPNP state. (D) Reconstruction of 
the PfK5ΔL6-MD no nucleotide state bound to αβ-tubulin after asymmetric unit refinement. 









corresponding cryo-EM density. (G) As in (F), for the AMPPNP state. In (F) and (G), key 
components of the PfK5ΔL6-MD are labelled and colour-coded as indicated. 
 
Figure 4. AMPNPP binding causes PfK5ΔL6-MD subdomain rearrangement and switch loop 
closure. (A) Rearrangements of PfK5ΔL6-MD switch loops upon AMPPNP binding, with a 
schematic showing connectivity of the switch loops to motor domain secondary structure 
elements on the left. Models and corresponding density are displayed on the right, with 
nucleotide binding loops coloured according to the schematic. The brown arrow indicates 
where there is missing density for loop11, and the grey arrow indicates connecting density 
between loop9 and 11. (B) Comparison of PfK5ΔL6-MD no nucleotide and AMPPNP 
nucleotide binding loops, demonstrating AMPPNP induced conformational changes. (C) The 
PfK5ΔL6-MD no nucleotide state model, coloured according to kinesin subdomain, with α 
and β-tubulin depicted in light and dark grey surface rendering respectively.  (D) PfK5ΔL6-
MD subdomain rearrangement, showing no overall movement in the tubulin-binding 
subdomain, with rotations in the P-loop subdomain shown on the left, and the switch-I/II 
subdomain on the right. 
 
Figure 5. AMPNPP binding supports PfK5ΔL6-MD cover neck bundle formation. (A) No 
nucleotide PfK5ΔL6-MD model and corresponding cryo-EM density of the cover neck bundle 
region. Helixα6/neck linker, the N-terminus, and loop13 are coloured according to the 
schematic. Note the lack of density for the neck linker at the terminus of helixα6. +/- 
symbols denote the MT polarity. Pink arrow indicates the lack of density for an ordered neck 
linker. (B) as in (A) for the AMPPNP state (at equivalent density thresholds), showing density 
corresponding to the neck linker docked along the motor domain and cover neck bundle 
formation (CNB), which is highlighted by the dotted black circle. 
 
Figure 6. PfK5ΔL6-MDhas an altered MT interface. (A) The PfK5ΔL6-MD no nucleotide state 
model in ribbon and coloured light blue. with secondary structure elements partaking in the 
MT interface coloured according to the key below. (B) As for in (A), for the PfK5ΔL6-MD 
AMMPNP state model, coloured in light orange. (C) Upper image – no nucleotide PfK5ΔL6-
MD density, rotated 90o from (A), and coloured according to αβ-tubulin when a particularly 
area of density is <7 Å away. Lower image - αβ-tubulin density from the no nucleotide state, 
coloured according to different PfK5ΔL6-MD secondary structure elements, as outlined in 
the key. (D) As in (C), for the PfK5ΔL6-MD AMPPNP state. 
 
Figure 7. PfK5ΔL6-MD loop5 alters the environment of the kinesin-5 drug binding site. (A) 
Primary sequence alignment of loop5 from HsK5 (UniProt ID: P52732), PfK5 (O77382) and 
various other Plasmodium species (Pv = vivax (A0A564ZV10), Pk = knowlesi (A0A1Y3DTC2), 
Pb = berghei (A0A122I4M3)). Conserved positions are coloured according to the ClustalX 
scheme, and a conservation score as calculated in Jalview is given below. (B) Loop5 density 
(grey) in the no nucleotide state, compared to other PfK5ΔL6-MD density (blue). (C) Loop5 
density (grey) in the AMPPNP state, compared to other PfK5ΔL6-MD density (left), and the 
PfK5ΔL6-MD model (right). (D) The STLC bound HsK5 crystal structure in lime (PDB ID: 
2WOG (45)), which was rigid body fitted into the PfK5ΔL6-MD AMPPNP state map. STLC is 
coloured purple, and HsK5 loop5 is coloured blue. PfK5ΔL6-MD loop5 cryo-EM density is 
depicted in grey. (E) Conservation of residues partaking in STLC binding between PfK5ΔL6-









residues contacting STLC were found using Chimera, and are displayed, with loop5 residues 
coloured blue, and residues from helicesα2-3 coloured green. Equivalent PfK5 residues are 
shown in grey with HsK5 residue labels. Non-conserved residues are displayed in red boxes, 
with conserved ones shown in black boxes. (F) ATPase rates of PfK5ΔL6-MD and HsK5 rate in 
the absence of MTs, with either no treatment, + 20 μM STLC, or DMSO (with the same % v/v 
as the % v/v of STLC). Statistical relationships were tested using a one-way ANOVA, followed 
by a post-hoc Tukey’s multiple comparison test. 
 
Table 1: Cryo-EM data collection, 3D Image Processing and model refinement statistics 
 PfK5ΔL6-MD nucleotide state 
 No Nucleotide AMPPNP 
Data Collection and 3D Image 
Processing 
 
Magnification 160,000 160,000 
Voltage (kV) 300 300 
Electron dose (e-/ Å2) 58 58 
Pixel size (Å) 1.39 1.39 
Number of Images 1320 335 
Data Collection Strategy manual and automated manual 
Starting number of particles 48,165 37,843 
Final particle number (after 
particle symmetry expansion) 
73,684 206,666 
Box size (pixels) 432 432 
C1 reconstruction resolution (Å) 4.5 4.8 
Asymmetric unit refine resolution 
(Å) 
4 4.4 
Model Refinement  
Global Cross-correlation:  
    Homology model 0.88 0.86 
    Final model 0.89 0.89 
MolProbity:   
    Homology model 3.46 3.46 
    Final model 1.13 0.98 
QMEAN   
    Homology model -2.21 -2.21 
    Final model -0.36 0.16 
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